查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1519817

2024-2032 年按疾病类型、治疗类型、最终用户和地区分類的心房颤动治疗市场报告

Atrial Fibrillation Treatment Market Report by Disorder Type, Treatment Type, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球心房颤动治疗市场规模达78亿美元。

心房颤动 (AFib) 是指心率不规则且过快的心臟疾病，会增加中风、心臟衰竭和其他心臟相关併发症的风险。在这种情况下，上腔（心房）跳动不规则，与心臟下腔（心室）不协调，导致心悸、气短和疲劳。它还可能导致血栓形成，从而扰乱流向其他器官的血液。 AFib 的主要类型包括阵发性、持续性、长期持续性和永久性 AFib，可以透过药物和其他干预措施来调整心臟的电脉衝来治疗。

心血管疾病（CVD）盛行率的上升是推动市场成长的关键因素之一。此类疾病在老年族群和患有其他疾病（例如糖尿病、高血压和心血管疾病（CVD））的个体中非常普遍。这加上全球老年人口的稳定成长，正在推动市场的成长。此外，人们对微创 (MI) 外科手术的日益青睐也对小型手术设备、植入手术和远端护理的需求产生了积极影响。此外，各种技术进步，例如用于去除受损心臟组织的导管消融装置的开发以及创新的绘图和记录系统，是另一个生长诱导因素。其他因素，包括医疗保健基础设施的改善以及医学领域广泛的研发（R＆D）活动，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球心房颤动治疗市场的表现如何，未来几年又将如何表现？
  • COVID-19 对全球心房颤动治疗市场有何影响？
  • 主要区域市场有哪些？
  • 基于无序类型的市场区隔是什么？
  • 根据治疗类型的市场划分是怎样的？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球心房颤动治疗市场的结构如何？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球心房颤动治疗市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场细分：依无序类型

  • 阵发性心房颤动
    • 市场走向
    • 市场预测
  • 持续性心房颤动
    • 市场走向
    • 市场预测
  • 永久性心房颤动
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依治疗类型

  • 医疗程序
    • 市场走向
    • 外科手术
      • 迷宫手术
      • 导管消融
    • 非手术器械
      • 电復律
      • 诊断导管
      • 测绘和记录系统
      • 心臟监测仪
      • 存取装置
      • 左心耳及封堵装置
      • 心内超音波心臟检查 (ICE) 系统
    • 市场预测
  • 药物
    • 市场走向
    • 药品类别
      • 抗凝血剂
      • 抗心律不整药
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 心臟实验室
    • 市场走向
    • 市场预测
  • 门诊手术中心
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Atricure Inc.
    • Biotronik
    • Boston Scientific Corporation
    • Cardiofocus Inc.
    • Hansen Medical Inc. (Auris Health)
    • Johnson & Johnson
    • Siemens Healthineers
    • Stereotaxis Inc.
Product Code: SR112024A2140

The global atrial fibrillation treatment market size reached US$ 7.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.5 Billion by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.

Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart's electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global atrial fibrillation treatment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on disorder type, treatment type and end-user.

Breakup by Disorder Type:

Paroxysmal Atrial Fibrillation

Persistent Atrial Fibrillation

Permanent Atrial Fibrillation

Others

Breakup by Treatment Type:

Medical Procedures

Surgical Procedures

Maze Surgery

Catheter Ablation

Non-Surgical Procedures

Electric Cardioversion

Diagnostic Catheters

Mapping and Recording Systems

Cardiac Monitors

Access Devices

Left Atrial Appendage and Closure Devices

Intracardiac Echocardiography (ICE) Systems

Medication

Anticoagulants

Anti-Arrhythmics

Breakup by End-User:

Hospitals

Cardiac Labs

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers, Stereotaxis Inc., etc.

Key Questions Answered in This Report:

  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global atrial fibrillation treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation treatment market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atrial Fibrillation Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Disorder Type

  • 6.1 Paroxysmal Atrial Fibrillation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Persistent Atrial Fibrillation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Permanent Atrial Fibrillation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Medical Procedures
    • 7.1.1 Market Trends
    • 7.1.2 Surgical Procedures
      • 7.1.2.1 Maze Surgery
      • 7.1.2.2 Catheter Ablation
    • 7.1.3 Non-Surgical Devices
      • 7.1.3.1 Electric Cardioversion
      • 7.1.3.2 Diagnostic Catheters
      • 7.1.3.3 Mapping and Recording Systems
      • 7.1.3.4 Cardiac Monitors
      • 7.1.3.5 Access Devices
      • 7.1.3.6 Left Atrial Appendage and Closure Devices
      • 7.1.3.7 Intracardiac Echocardiography (ICE) Systems
    • 7.1.4 Market Forecast
  • 7.2 Medications
    • 7.2.1 Market Trends
    • 7.2.2 Drug Class
      • 7.2.2.1 Anticoagulants
      • 7.2.2.2 Anti-Arrhythmics
    • 7.2.3 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Atricure Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biotronik
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Boston Scientific Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 Cardiofocus Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Hansen Medical Inc. (Auris Health)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Johnson & Johnson
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Siemens Healthineers
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Stereotaxis Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Atrial Fibrillation Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Atrial Fibrillation Treatment Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Atrial Fibrillation Treatment Market: Breakup by Disorder Type (in %), 2023
  • Figure 4: Global: Atrial Fibrillation Treatment Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Atrial Fibrillation Treatment Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Atrial Fibrillation Treatment Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Atrial Fibrillation Treatment (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Atrial Fibrillation Treatment (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Atrial Fibrillation Treatment (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Atrial Fibrillation Treatment (Medical Procedures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Atrial Fibrillation Treatment Market (Medical Procedures): Breakup by Type (in %), 2023
  • Figure 18: Global: Atrial Fibrillation Treatment Market (Surgical Procedures): Breakup by Type (in %), 2023
  • Figure 19: Global: Atrial Fibrillation Treatment (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Atrial Fibrillation Treatment (Medication) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Atrial Fibrillation Treatment Market (Medication): Breakup by Drug Classes (in %), 2023
  • Figure 22: Global: Atrial Fibrillation Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Atrial Fibrillation Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Atrial Fibrillation Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Atrial Fibrillation Treatment (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Atrial Fibrillation Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Atrial Fibrillation Treatment (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Atrial Fibrillation Treatment (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: North America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: North America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: United States: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: United States: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Canada: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Canada: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Asia Pacific: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Asia Pacific: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: China: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: China: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Japan: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Japan: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: India: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: India: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: South Korea: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: South Korea: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Australia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Australia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Indonesia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Indonesia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Europe: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Europe: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Germany: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Germany: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: France: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: France: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: United Kingdom: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: United Kingdom: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Italy: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Italy: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Spain: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Spain: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Russia: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Russia: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Latin America: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Latin America: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Brazil: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Brazil: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Mexico: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Mexico: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Middle East and Africa: Atrial Fibrillation Treatment Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Middle East and Africa: Atrial Fibrillation Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Atrial Fibrillation Treatment Industry: SWOT Analysis
  • Figure 80: Global: Atrial Fibrillation Treatment Industry: Value Chain Analysis
  • Figure 81: Global: Atrial Fibrillation Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atrial Fibrillation Treatment Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Disorder Type (in Million US$), 2024-2032
  • Table 3: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Atrial Fibrillation Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Atrial Fibrillation Treatment Market Structure
  • Table 7: Global: Atrial Fibrillation Treatment Market: Key Players